Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-16 4:35 pm Purchase | 13G | CERUS CORP CERS | BAKER BROS. ADVISORS LP | 13,733,059 8.2% | 2,963,258 (+27.51%) | View |
2021-02-16 4:27 pm Sale | 13G | KRYSTAL BIOTECH INC KRYS | BAKER BROS. ADVISORS LP | 698,874 3.5% | -335,800 (-32.45%) | View |
2021-02-16 4:22 pm Purchase | 13G | ALTIMMUNE INC ALT | BAKER BROS. ADVISORS LP | 1,884,451 5.1% | 1,884,451 (New Position) | View |
2021-02-16 4:16 pm Purchase | 13G | VERASTEM INC VSTM | BAKER BROS. ADVISORS LP | 10,144,039 6% | 10,144,039 (New Position) | View |
2021-02-16 4:08 pm Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | BAKER BROS. ADVISORS LP | 58,985,262 6.4% | 58,985,262 (New Position) | View |
2021-02-05 4:53 pm Unchanged | 13G | ZYMEWORKS INC ZYME | BAKER BROS. ADVISORS LP | 4,909,810 9.99% | 0 (Unchanged) | View |
2021-01-29 5:03 pm Purchase | 13D | IGM BIOSCIENCES INC IGMS | BAKER BROS. ADVISORS LP | 3,157,784 12.4% | 513 (+0.02%) | View |
2021-01-29 4:55 pm Purchase | 13D | ZYMEWORKS INC ZYME | BAKER BROS. ADVISORS LP | 4,909,810 9.99% | 47,396 (+0.97%) | View |
2021-01-29 4:48 pm Purchase | 13D | Prelude Therapeutics Inc PRLD | BAKER BROS. ADVISORS LP | 10,126,417 28.8% | 5,189 (+0.05%) | View |
2021-01-29 4:38 pm Sale | 13G | ACERAGEN INC ACGN | BAKER BROS. ADVISORS LP | 4,641,311 12.1% | -54,791 (-1.17%) | View |
2021-01-05 5:14 pm Sale | 13D | IGM BIOSCIENCES INC IGMS | BAKER BROS. ADVISORS LP | 3,157,271 12.4% | -35,751 (-1.12%) | View |
2020-12-23 5:11 pm Purchase | 13D | NEUROGENE INC NGNE | BAKER BROS. ADVISORS LP | 4,229,827 9.99% | 424,827 (+11.16%) | View |
2020-12-11 5:28 pm Purchase | 13D | IGM BIOSCIENCES INC IGMS | BAKER BROS. ADVISORS LP | 3,193,022 9.99% | 49,022 (+1.56%) | View |
2020-12-04 5:24 pm Sale | 13D | BEIGENE LTD SPONSORED ADR BGNE | BAKER BROS. ADVISORS LP | 154,315,490 13% | -19,650,098 (-11.30%) | View |
2020-11-24 4:12 pm Purchase | 13D | KODIAK SCIENCES INC KOD | BAKER BROS. ADVISORS LP | 14,054,698 27.6% | 1,778,949 (+14.49%) | View |
2020-09-30 5:25 pm Purchase | 13D | Prelude Therapeutics Inc PRLD | BAKER BROS. ADVISORS LP | 10,121,228 31.1% | 10,121,228 (New Position) | View |
2020-09-08 5:24 pm Purchase | 13D | KODIAK SCIENCES INC KOD | BAKER BROS. ADVISORS LP | 12,275,749 27.3% | 701,212 (+6.06%) | View |
2020-07-28 5:29 pm Purchase | 13D | Kiniksa Pharmaceuticals Ltd. KNSA | BAKER BROS. ADVISORS LP | 2,903,030 9.2% | 6,253 (+0.22%) | View |
2020-07-17 5:22 pm Purchase | 13D | BEIGENE LTD SPONSORED ADR BGNE | BAKER BROS. ADVISORS LP | 173,965,588 14.9% | 14,846,728 (+9.33%) | View |
2020-05-19 5:26 pm Sale | 13D | Seagen Inc. SGEN | BAKER BROS. ADVISORS LP | 47,615,277 27.5% | -1,750,000 (-3.55%) | View |